Cargando…
Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response
Neoadjuvant systemic therapy (NST) is widely applied in breast cancer treatment, but individuals respond differently to the same NST regimen. It is unclear which patients should adjust their NST regimen and what such an adjustment should be, especially for patients with radiologically partial respon...
Autores principales: | Xu, Yinggang, Zhang, Weiwei, Wang, Siqi, Xu, Lu, Xu, Haiping, Chen, Rui, Shi, Xiaoqing, Huang, Xiaofeng, Wang, Ye, He, Jinzhi, Shi, Wenjie, Wan, Xinyu, Wang, Jue, Zha, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939658/ https://www.ncbi.nlm.nih.gov/pubmed/36814820 http://dx.doi.org/10.3389/fonc.2023.910869 |
Ejemplares similares
-
Prognostic analysis of three forms of Ki‐67 in patients with breast cancer with non‐pathological complete response before and after neoadjuvant systemic treatment
por: Zhang, Weiwei, et al.
Publicado: (2023) -
A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer
por: Shi, Wenjie, et al.
Publicado: (2022) -
Corrigendum: A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer
por: Shi, Wenjie, et al.
Publicado: (2022) -
Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis
por: Xu, Yinggang, et al.
Publicado: (2022) -
Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
por: Hong, Jin, et al.
Publicado: (2021)